Publicaciones en colaboración con investigadoras/es de Harvard Medical School (9)

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2013

  1. Acetylation and deacetylation - Novel factors in muscle wasting

    Metabolism: Clinical and Experimental, Vol. 62, Núm. 1, pp. 1-11

  2. CaMKII activity is reduced in skeletal muscle during sepsis

    Journal of Cellular Biochemistry, Vol. 114, Núm. 6, pp. 1294-1305

  3. PPARβ/δ Regulates Glucocorticoid- and Sepsis-Induced FOXO1 Activation and Muscle Wasting

    PLoS ONE, Vol. 8, Núm. 3

  4. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes

    Metabolism: Clinical and Experimental, Vol. 62, Núm. 10, pp. 1495-1502

2012

  1. Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 303, Núm. 10

  2. Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism

    Biochemical and Biophysical Research Communications, Vol. 417, Núm. 1, pp. 528-533

  3. β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy

    Biochemical and Biophysical Research Communications, Vol. 423, Núm. 4, pp. 739-743